Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Loss of revenue due to medication non-adherence globally and U.S. 2012 vs. 2016

Loss of revenue due to medication non-adherence globally and in the U.S. 2012 vs. 2016 (in billion U.S. dollars)

by Matej Mikulic, last edited Mar 29, 2018
Loss of revenue due to medication non-adherence globally and U.S. 2012 vs. 2016 This statistic shows the loss of revenue due to medication non-adherence globally and in the U.S. in 2012 and in 2016. It shows that the pharmaceutical revenue loss globally was 564 billion U.S. dollars in 2012 and 637 billion U.S. dollars in 2016 due to non-adherence.
Show more

Loss of revenue due to medication non-adherence globally and in the U.S. 2012 vs. 2016 (in billion U.S. dollars)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Digital health"
  • Overview
The most important statistics
  • mHealth
  • Telehealth/telemedicine
  • EHR/EMR
  • Big data
  • The consumer's view
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.